Transforming growth factor-α: A surrogate endpoint biomarker?

Journal of the American College of Surgeons

Volumn 195, Issue 2, 2002, Pages 149-158

  Beenken, Samuel W ^a,f   Hockett Jr , Richard ^d   Grizzle, William ^b   Weiss, Heidi L ^c   Pickens, Allan ^a   Perloff, Marjorie ^e   Malone, Winfred F ^e   Bland, Kirby I ^a  

^a Kentucky   (United States)

^b AL ^*  (United States)

^c Department of Pharmacology and Toxicology and Mass Spectrometry Core Facility   (United States)

^d ELI LILLY AND COMPANY   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; ISOTRETINOIN; TRANSFORMING GROWTH FACTOR ALPHA;

ARTICLE; CANCER PREVENTION; CANCER RISK; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; LEUKOPLAKIA; MESSENGER RNA SYNTHESIS; MOUTH MUCOSA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA;

AGED; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ISOTRETINOIN; LEUKOPLAKIA, ORAL; MALE; MOUTH NEOPLASMS; PROSPECTIVE STUDIES; RECEPTOR, EPIDERMAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR MARKERS, BIOLOGICAL;

EID: 0036339050     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(02)01219-X     Document Type: Article

References (53)

1. The multistep nature of cancer development
2. Dysregulation of epidermal growth factor receptor (EGFR) expression in the multistage process of head and neck carcinogenesis
3. Activation of p53 expression in premalignant lesions during head and neck tumorigenesis
4. Micronucleated exfoliated cells as indicators for genotoxic damage and as markers in chemoprevention trials
5. "Field cancerization" in oral stratified squamous epithelium: Clinical implications of multicentric origin
6. Beta-carotene
7. Strategies for chemoprevention study of premalignant lesions and second primary tumors in the head and neck
8. Retinoid chemoprevention of upper aerodigestive tract carcinogenesis
9. Head and neck cancer
10. Biochemical treatment of precancerous oral lesions: The effectiveness of various analogues of retinoic acid
11. Effects of retinoids on oral leukoplakia
12. 13-Cis retinoic acid in the treatment of oral leukoplakia
13. Management of oral mucosal dysplasia with beta-carotene and 13-cis retinoic acid: A pilot crossover study
14. Suppression of retinoic acid receptor-β in premalignant lesions and its upregulation by isotretinoin
15. Prevention of second primary tumors with isotretinoin in squamous cell carcinoma of the head and neck
16. Prevention of second primary tumors with isotretinoin in patients with squamous cell carcinoma of the head and neck: Long term follow-up
17. Retinoid modulation of biomarkers in oral leukoplakia/dysplasia
18. Transforming growth factor α (TGF-α) expression in dysplastic oral leukoplakia: Modulation by 13-cis retinoic acid
19. Quantitative, competitive RT-PCR analysis of biomarkers in the study of neoplasia
20. Simultaneous quantitation of multiple cytokine mRNAs by RT-PCR using plate based EIA methodology
21. Surrogate end points in cancer research: A critique
22. Molecular themes in oncogenesis
23. Dimerization of cell surface receptors in signal transduction
24. Autoregulatory mechanisms in protein-tyrosine kinases
25. Protein modules and signaling networks
26. Infection with a TGF-α retroviral vector transforms normal mouse mammory epithelial cells but not normal rat fibroblasts
27. Synthesis of messenger RNAs for transforming growth factors-α and -β and the epidermal growth factor receptor by human tumors
28. Production of TGF-α and TGF-β by altered keratinocytes, skin and oral squamous cell carcinomas: Potential autocrine regulation of normal and malignant epithelial cell production
29. EGF and TGF-α, the ligands of hyperproduced EGFR in human esophageal carcinoma cells, act as autocrine growth factors
30. TGF-α and EGF receptor mRNAs in human oral cancers
31. Epidermal growth factor gene amplification and expression in head and neck cancer cell lines
32. Immunohistochemical localization of epidermal growth factor (EGF) and EGF receptor in human oral mucosa and its malignancy
33. Quantitative assay of epidermal growth factor receptor in human squamous cell carcinomas of the oral region by an avidin-biotin method
34. Retinoids, retinoid-responsive genes, cell differentiation, and cancer
35. Amplified and overexpressed epidermal growth factor receptor gene in uncultured primary human breast carcinoma
36. High incidence of amplification of the epidermal growth factor receptor gene in human squamous cell carcinoma cell lines
37. Int-2 amplification in breast cancer: Association with decreased survival and relationship to amplification of c-erbB-2 and c-myc
38. Amplification of human int-2 in breast cancers and squamous carcinomas
39. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene
40. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer
41. The prognostic significance of amplification and overexpression of c-met and c-erbB-2 in human gastric carcinomas
42. bFGF as an autocrine growth factor for human melanomas
43. Expression of scatter factor and c-met receptor in benign and malignant breast tissue
44. A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences
45. High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma
46. Trk-T1 is a novel oncogene formed by the fusion of tpr and trk genes in a human papillary thyroid carcinoma
47. PTC is a novel rearranged form of the ret protooncogene and is frequently detected in vivo in human thyroid papillary carcinomas
48. Gain-of-function mutations on c-kit in human gastrointestinal stromal tumors
49. Somatic mutations in the kinase domain of the Met/hepatocyte growth factor receptor gene in childhood hepatocellular carcinomas
50. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC
51. Germline mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A
52. Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B
53. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma